Regeneron Pharmaceuticals (REGN)
Operating Income Growth
31.59%
Quarterly · Period ending:
REGN Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported31.59%period ending
Latest reported31.59%period ending
REGN Quarterly Operating Income YoY % (66.67% → 31.59%)
Year-over-year change
High-resolution chart · PNG
REGN operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -365.8681% | |
| -73.4788% | |
| -1,258.5714% | |
| -203.6667% | |
| 53.7857% | |
| 18.4615% | |
| 88.7097% | |
| -112.5% | |
| -1,300% | |
| -112.2449% | |
| -616.6667% | |
| -118.1818% | |
| 118.9189% | |
| -19.5122% | |
| 126.6667% | |
| 75% | |
| 0% | |
| 12.766% | |
| -66.6667% | |
| -83.3333% | |
| -184.6154% | |
| -291.6667% | |
| 47.0588% | |
| 35.1351% | |
| 87% | |
| 88.4615% | |
| 54.4643% | |
| 60.2151% | |
| -2.0408% | |
| -13.0435% | |
| -83.6066% | |
| -66.0714% | |
| -180% | |
| -187.5% | |
| -64.8649% | |
| -124% | |
| -75% | |
| -260% | |
| 47.1429% | |
| -292.3077% | |
| -266.6667% | |
| 66.6667% |